A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination
Juliana Cassataro, Karina A. Pasquevich, Silvia M. Estein, Diego A. Laplagne, Carlos A. Velikovsky, Silvia de la Barrera, Raúl Bowden, Carlos A. Fossati, Guillermo H. Giambartolomei, Fernando A. GoldbVolume:
25
Year:
2007
Language:
english
DOI:
10.1016/j.vaccine.2007.03.028
File:
PDF, 433 KB
english, 2007